Search

Issue
Title
Authors
The effect of extended release metformin on MRI parameters of left ventricular remodeling in patients with prediabetes and heart failure with preserved ejection fraction
Tsygankova O.V., Apartseva N.E., Latyntseva L.D., Nikitin N.A.
LOX-1 as a biological marker and therapeutic target in cardiovascular pathology (literature review)
Alieva A.M., Baykova I.E., Reznik E.V., Teplova N.V., Valiev R.K., Gyzyeva M.K., Sultangalieva A.B., Kotikova I.A., Novikova N.A., Korvyakov S.A., Nikitin I.G.
Cardiomyopathy associated with the use of anabolic androgenic steroids. Case report
Charaya K.V., Erdniev T.N., Makarenko G.D., Chashkina M.I., Gogiberidze N.A., Dumikyan A.S., Shchekochikhin D.Y., Chomakhidze P.S., Poltavskaya M.G., Andreev D.A.
SGLT-2 inhibitors in the management of acute decompensated heart failure
Poskakalova A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Differential diagnosis of amiodarone-induced thyrotoxicosis in a patient with atrial fibrillation and agranulocytosis on the background of thyrostatic therapy. Case report
Zherebchikova K.Y., Bubnov D.S., Ermolaeva A.S., Soltakhanova M.O., Sych Y.P., Ezhov M.V., Fadeev V.V.
Asthma and cardiovascular disease
Ostroumova O.D., Goloborodova I.V., Voevodina N.Y., Fomina V.M., Seregin A.A.
Cardiovascular diseases in the long-term after surviving malignant neoplasms: A review
Poltavskaya M.G., Novikova A.I., Bezlyudskiy A.L.
Myocardial cytoprotection in the treatment of patients with coronary artery disease: Complex clinical cases
Darenskiy D.I.
Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region)
Airapetian A.A., Lazareva N.V., Reitblat O.M., Mezhonov E.M., Evgeny E.V., Prints Y.S., Zhirov I.V., Tereshchenko S.N., Boytsov S.A.
Ischemic heart disease and heart rate monitoring
Kirichenko A.A.
Effectiveness and safety of bronchodilator use in chronic cardiac insufficiency of ischemic genesis comorbid with chronic obstructive pulmonary disease
Evdokimov V.V., Evdokimova A.G., Kovalenko E.V., Voronina G.V.
POSSIBILITIES OF PHARMACEUTICAL TREATMENT OF CARDIOGENIC ENCEPHALOPATHY WITH THE USE OF RUSSIAN MEDICATION WITH METABOLIC ACTION LEVOCARNITINE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CONGESTIVE HEART FAILURE
Mozheiko M.E., Bushueva E.V., Potanina M.V., Ryabikhin E.A.
WHICH ASPECTS ARE THE MOST SIGNIFICANT IN RUSSIAN AND EUROPEAN GUIDELINES? INTERVIEW
Allopurinol in the complex therapy of acute decompensation of heart failure
Sarieva L.H., Muksinova M.D., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Fatal cardio-vascular events risk stratification in ischemic heart disease patients with implantable cardioverter-defibrillators: role of noninvasive electrophysiological predictors
Melnik N.V., Tsaregorodtsev D.A., Ilych I.L., Khamnagadaev I.A., Sulimov V.A.
Trimetazidine (review of the latest foreign publications)
Akatova E.V.
The current status of transcatheter heart valve replacement, using the valve-in-valve technique
Imaev T.E., Komlev A.E., Kolegaev A.S., Lepilin P.M., Akchurin R.S.
Predictors of class IC antiarrhythmic drugs efficacy in patients with paroxysmal form of atrial fibrillation
Khalikova M.A., Tsaregorodtsev D.A., Beraya M.M., Sedov A.V.
Efficacy and safety of long-term use of prolonged bronchodilators in patients with cardiopulmonary pathology and chronic heart failure
Evdokimov V.V., Yushchuk E.N., Evdokimova A.G., Stryuk R.I.
Captopril effectiveness in treatment of patients with congestive heart failure and cardiopulmonary pathology
Evdokimov V.V., Evdokimova A.G., Kovalenko E.V., Tereshchenko O.I.
Inhibitor If-sinus channels ivabradine - a drug, increases the effectiveness of treatment of chronic heart failure and coronary heart disease
Trukhan D.I.
The role of percutaneous coronary intervention in the treatment of patients with multivessel coronary artery disease who are turned down for coronary artery bypass grafting (literature review)
Zaynobidinov S.S., Khelimskii D.A., Baranov A.A., Badoian A.G., Tsydenova A.Y., Naydenov R.A., Krestyaninov O.V.
Non-alcoholic fatty liver disease and cardiovascular risks: A review
Kotovskaya Y.V.
Anatomy of the coronary arteries and localization of coronary atherosclerosis in siblings with coronary heart disease
Kamolov I.H., Semitko S.P., Zhuravlev A.S., Chernysheva I.E., Tsereteli N.V., Sandodze T.S., Azarov A.V., Fomin V.V., Ioseliani D.G.
Captopril in cardiological patients treatment: is there still place for the “first of the Mohicans”?
Valikulova F.Y., Koroleva L.Y., Melnichenko O.V., Duryndina E.M., Muradova F.N., Alekseeva M.M.
Neopterin is a biomarker of chronic heart failure (review of modern literature)
Alieva A.M., Pinchuk T.V., Voronkova K.V., Shnakhova L.M., Ettinger O.A., Akhmedova M.F., Valiev R.K., Kalova M.R., Gasanova E.T., Nikitin I.G.
Sodium-glucose co-transporter-2 inhibitors in patients with heart failure. What's new? What are the prospects?
Erlikh A.D., Riabova D.V.
Difficulties in diagnosis and variants of the clinical course of hypertrophic cardiomyopathy in elderly patients
Krylova N.S., Maslova M.Y., Poteshkina N.G., Kovalevskaya E.A., Selivanova G.B.
SECONDARY PREVENTION IN STABLE ANGINA
Kirichenko A.A.
Cystatin C allows to detect early progression of chronic kidney disease in patients with acute decompensation of chronic heart failure
Davydov V.V., Arechina E.L.
Vybor effektivnogo diuretika dlya terapii khronicheskoy serdechnoy nedostatochnosti na ambulatornom etape: dovody v pol'zu torasemida
Larina V.N.
Angiotensin receptor blockers II in the treatment of arterial hypertension in patients with comorbid pathology: the possibilities of candesartan
Trukhan D.L., Davydov E.L.
Therapy for chronic heart failure: the possibilities of eplerenone
Vertkin A.L., Abdullaeva A.U., Knorring G.Y.
The first case of Absorb bioresorbable vascular scaffold implantation in child with complex congenital heart defect and acute coronary syndrome
Shmatkov M.G., Chernogrivov A.E., Allenov A.A., Morozov Z.A., Bazylev V.V.
Ivabradine in the complex therapy of coronary heart disease and coronary heart disease complications
Shalaev S.V., Abaturova O.V., Kremneva L.V.
The application of calcium channel blockers in patients with cardiovascular disease: focus on the diltiazem
Zadionchenko V.S., Shehyan G.G., Yalymov A.A., Schikota A.M., Sherstyannikova O.M., Asymbekova E.U.
Cardiac amyloidosis in the practice of a cardiologist and therapist. Case report
Nikiforova T.V., Magomedova Z.М., Magaramova M.F., Pershina E.S., Shchekochikhin D.Y., Andreev D.A.
Difference of genetic polymorphisms in patients with type 2 diabetes mellitus with absence or presence of chronic heart failure with preserved ejection fraction
Sveklina T.S., Shustov S.B., Kolyubaeva S.N., Kuchmin A.N., Kozlov V.A., Halimov Y.S., Konyaev V.V.
A clinical case of hereditary transthyretin amyloidosis. Case report
Shoshina A.A., Nasonova S.N., Zhirov I.V., Saidova M.A., Ansheles A.A., Meshkov A.N., Tereshchenko S.N.
Therapy correction of concerned chronic heart failure and chronic obstructive pulmonary disease in a patient with first identified pulmonary tuberculosis. Case report
Bagisheva N.V., Mordyk A.V., Trukhan D.I., Viktorova I.A., Moiseeva M.V.
Antagonists of mineralocorticoid receptors in the treatment of patients with post-infarced heart failure: the role of eplerenon
Kashtalap V.V., Sedykh D.Y., Barbarash O.L.
Acute heart failure: classification, diagnosis, general approaches to treatment
Zhirov I.V., Nasonova S.N., Khalilova U.A., Osmolovskaya Y.F., Chaikovskaia O.I., Zhirova I.A., Gimadiev R.R., Kochetov A.G., Tereshchenko S.N.
Adherence to drug therapy in patients with chronic coronary heart disease after percutaneous coronary interventions
Gapon L.I., Samoilova E.P., Bessonov I.S., Gultyaeva E.P., Berdinsky S.G.
Hyperuricemia and chronic heart failure: risk factors and prognostic parallels
Larina V.N., Larin V.G.
STABLE ISCHEMIC HEART DISEASE. A REVISION OF MANAGEMENT AND CLASSIFICATION. WE ARE WAITING FOR CHANGES. CLINICAL CASES: BEST PRACTICE
Adasheva T.V., Samorukova E.I., Akhmedyarova L.B., Odintsova D.V.
Anxiety and depressive disorders in cardiology practice. Possibilities of using D,L-Hopantenic acid
Ostroumova O.D., Goloborodova I.V., Fomina V.M., Bondarets O.V.
Edema pharmacotherapy in patients with hepatic cirrhosis and congestive heart failure: loop diuretics in focus
Ketova G.G., Popov A.Y., Babich A.E., Luchinina E.V.
Correction of late violations of atrioventricular conduction in patients with lower myocardial infarction: the case of ivabradin
Loukianova I.Y., Shishkin A.N.
Small abnormalities of the heart and an open oval window: myths and reality
Rybakova M.K., Mitkov V.V., Baldin D.G.
Methods of cardiovascular imaging for the detection of ischemic heart disease
Nikiforov V.S.
Molecular genetic diagnosis of predisposition to the development of coronary heart disease: modern state of the problem
Meshkov A.N., Shcherbakova N.V.
Obstructive sleep apnea syndrome and cardiovascular events
Litvin A.Y., Mikhailova O.O., Elfimova E.M., Chazova I.E.
The characteristics of torasemide - loop diuretic application in patients with compensated heart failure
Ovchinnikov A.G.
Exogenous ketone therapy for heart failure: A review
Aksenova Y.O., Osmolovskaya Y.F., Zhirov I.V., Beniashvili A.G., Morozova M.A., Tereshchenko S.N.
The effect of active diuretic therapy on the sodium balance in patients with acute decompensation of chronic heart failure
Davydov V.V., Arehina E.L.
Chronic heart failure in the practice of the therapist: is it difficult to recognize it?
Kirichenko A.A., Ebseeva E.Y.
Dinical value of blood biomarker ST2 in patients with chronic heart failure
Alieva A.M., Pinchuk T.V., Almazova I.I., Ettinger O.A., Valiev R.K., Batov M.A., Nikitin I.G.
Heart failure and contrast-induced acute kidney injury in patients with coronary artery disease
Mironova O.I., Sivakova O.A., Deev A.D., Fomin V.V.
Management of patients with chronic heart failure and diabetes mellitus from the standpoint of modern recommendations and in real clinical practice
Reznik E.V., Lazarev V.A., Kalova M.R., Nikitin I.G.
PREVENTION AND OVERCOMING OF CARDIOTOXIC EFFECT OF CANCER THERAPY. INTERVIEW
Amyloid heart disease: pathomorphology, diagnostic approaches and treatment options
Rameeva A.S., Rameev V.V., Moiseev S.V., Tao P.P., Kozlovskaya L.V.
Chronic obstructive pulmonary disease and comorbid cardiovascular disease: in the context of guidelines
Ostroumova O.D., Kochetkov A.I.
The role of antagonists of mineralocorticoid receptors in the pharmacotherapy of chronic heart failure
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Dronova Y.M.
Ivabradine in clinical practice
Syrov A.V.
Autonomic heart neuropathy and its correction in type 2 diabetic patients
Krutikov E.S., Tsvetkov V.A., Chistyakova S.I.
Non-compact myocardium of the left ventricle: secondary prevention of thromboembolic complications
Myasnikov R.P., Kulikova O.V., Kharlap M.S., Koretskiy S.N., Andreenko E.Y., Mershina E.A., Sinitsyn V.E., Boytsov S.A.
The relationship between metabolic disorders and insulin resistance in patients with diabetes mellitus
Dorofeeva G.B., Dorofeev I.V.
Possibilities of hyperuricemia correction in acute decompensation of heart failure
Sarieva L.H., Nasonova S.N., Muksinova M.D., Zhirov I.V., Tereshchenko S.N.
Molecular mechanisms of inflammation in the development of heart failure: A review
Buziashvili Y.I., Asymbekova E.U., Tugeeva E.F., Rakhimov A.Z., Shakhnazaryan L.S., Akildzhonov F.R.
Endocan is a key player in cardiovascular disease: A review
Alieva A.M., Reznik E.V., Baykova I.E., Teplova N.V., Makeeva L.M., Voronkova K.V., Khadzhieva N.K., Modestova A.V., Totolyan G.G., Valiev R.K., Li A.M., Kotikova I.A., Nikitin I.G.
Pentraxin-3 – a promising biological marker in heart failure: literature review
Alieva A.M., Teplova N.V., Batov M.A., Voronkova K.V., Valiev R.K., Shnakhova L.M., Pinchuk T.V., Rakhaev A.M., Kalova M.R., Nikitin I.G.
Tactics of management of patients with cardiovascular diseases. Roundtable report
Konradi A.O., Baranova E.I., Gurevich V.S., Zvartau N.E., Konstantinov V.O., Nifontov E.M., Obrezan A.G., Panov A.V., Sitnikova M.Y.
AUTONOMIC DYSREFLEXIA IN TETRAPLEGIA AFTER SPINAL CORD INJURY: ORIGINAL ARTICLE
Bushkov F.A., Salyukov R.V.
Algorithm for antihypertensive therapy choice: focus on candesartan
Shekhyan G.G., Yalymov A.A., Shchikota A.M., Timofeeva N.Y., Zadionchenko V.S., Terpigorev S.A., Nikishenkov A.M., Kabanova T.G.
Treatment of chronic heart failure and arterial hypertension: two aims and one drug - fosinopril
Trukhan D.I.
Treatment of chronic heart failure and arterial hypertension: two aims and one drug - torasemide
Trukhan D.I.
Modern possibilities of torasemide application in clinical practice
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Evstigneeva A.S.
Angiotensin II receptor antagonist - candesartan in the arsenal of therapist
Kirichenko A.A.
Glycemic control as a part of coronary stenosis prevention strategy in type 2 diabetes patients before and after transcutaneous coronary intervention
Salukhov V.V., Kadin S.V., Agliullin A.F.
Key features of candesartan application in clinical practice
Evdokimova A.G., Lozhkina M.V., Kovalenko E.V.
Vaccine prophylaxis in patients with chronic obstructive pulmonary disease: results of a two-year observation
Ignatova G.L., Antonov V.N., Rodionova O.V.
Tumor necrosis factor gene polymorphism rs1800629 in patients with atherosclerotic cardiovascular diseases: A review
Khazova E.V., Bulashova O.V., Valeeva E.V.
Study of the rs1800795 polymorphism of the IL6 gene to verify the clinical portrait of a patient with chronic heart failure: gender aspects
Khazovа E.V., Boulashova O.V., Valeeva E.V.
Rational drug therapy of chronic heart failure: the role of mineralocorticoid receptor antagonists: review
Safronova N.V., Zhirov I.V., Tereshchenko S.N.
The relevance of prescribing triple neurohormonal blockade in real clinical practice: the role of mineralocorticoid receptor antagonists
Zhirov I.V.
P2-ADRENERGIC RECEPTORS GENETIC POLYMORPHISM, CARDIOVASCULAR DISORDERS AND INFLUENCE OF P-BLOCKERS’ EFFECTIVENESS
Leonova M.V.
MILDRONATE USE IN COMPLEX TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ITS INFLUENCE ON HEART AND VESSELS MORPHOFUNCTIONAL STATE
Mikhin V.P., Khlebodarov F.E., Vasil'eva D.A., Gromnatskii N.I.
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: A CHOICE OF THE DRUG IN CLINICAL PRACTICE GIVEN THE EFFECTIVENESS AND SAFETY OF USE
Mubarakshina O.A., Liubavskaia S.S., Somova M.N., Batishcheva G.A.
Percutaneous coronary interventions in comparison with medical therapy in patients with chronic ischemic heart disease: results of long-term follow-up
Kuznetsov V.A., Samoilova E.P., Bessonov I.S., Gultyaeva E.P., Berdinskikh S.G., Gorbatenko E.A., Dyachkov S.M., Yaroslavskaya E.I.
Decreased cardiac mortality with nicorandil in patients with ischemic heart failure
Yoshihisa A., Sato Y., Watanabe S., Yokokawa T., Sato T., Suzuki S., Oikawa M., Kobayashi A., Takeishi Y.
The mineralocorticoid receptor blockers in the treatment of chronic heart failure
Kirichenko A.A.
Clinical aspects of application of candesartan
Rybachkova Y.V.
Liver damage in patients with ischemic chronic heart and type 2 diabetes - a treacherous tandem: possible additional organoprotective therapy
Statsenko M.E., Turkina S.V., Shilina N.N.
The characteristics of torasemide application in patients with arterial hypertension and chronic heart failure
Evdokimov V.V., Evdokimova A.G., Lozhkina M.V., Tebloev K.I.
Aggravation of coronary heart disease: the balance of risk and the risk of disease treatment
Braznik V.A., Zateyshchikov D.A.
Dynamics of uric acid concentration against the background of early dapagliflozin use in patients with acute decompensation of heart failure
Sarieva L.H., Poskakalova A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Sodium-glucose cotransporter 2 inhibitors: mechanisms of cardiorenal protection: A review
Leonova M.V.
The role of interleukin-27 in atherosclerotic cardiovascular diseases: A review
Alieva A.M., Teplova N.V., Reznik E.V., Sarakaeva L.R., Rahaev A.M., Elmurzaeva D.A., Akkiev M.I., Shavaeva M.Y., Akkieva M.A., Nikitin I.G.
Heart failure as a complication of myocardial infarction: rational therapy. Case report
Zhirov I.V., Safronova N.V., Tereshchenko S.N.
Chronic heart failure – modification of treatment paradigm
Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
1 - 100 of 145 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».